Aclaris Therapeutics Inc (NASDAQ:ACRS) saw a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 3,060,000 shares, a decline of 16.6% from the January 15th total of 3,670,000 shares. Approximately 9.2% of the shares of the company are sold short. Based on an average daily […]
